These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9612801)

  • 1. Muscle maturation: implications for gene therapy.
    van Deutekom JC; Hoffman EP; Huard J
    Mol Med Today; 1998 May; 4(5):214-20. PubMed ID: 9612801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic administration of naked DNA: gene transfer to skeletal muscle.
    Liu F; Liang KW; Huang L
    Mol Interv; 2001 Aug; 1(3):168-72. PubMed ID: 14993350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy of Duchenne muscular dystrophy.
    Fassati A; Murphy S; Dickson G
    Adv Genet; 1997; 35():117-53. PubMed ID: 9348647
    [No Abstract]   [Full Text] [Related]  

  • 4. Systemic gene transfer to skeletal muscle using reengineered AAV vectors.
    Phillips JL; Hegge J; Wolff JA; Samulski RJ; Asokan A
    Methods Mol Biol; 2011; 709():141-51. PubMed ID: 21194026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus VP22 enhances adenovirus-mediated microdystrophin gene transfer to skeletal muscles in dystrophin-deficient (mdx) mice.
    Xiong F; Xiao S; Peng F; Zheng H; Yu M; Ruan Y; Li W; Shang Y; Zhao C; Zhou W; Chen H; Chamberlain JS; Fang L; Zhang C
    Hum Gene Ther; 2007 Jun; 18(6):490-501. PubMed ID: 17550336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral gene delivery to skeletal muscle: insights on maturation-dependent loss of fiber infectivity for adenovirus and herpes simplex type 1 viral vectors.
    Feero WG; Rosenblatt JD; Huard J; Watkins SC; Epperly M; Clemens PR; Kochanek S; Glorioso JC; Partridge TA; Hoffman EP
    Hum Gene Ther; 1997 Mar; 8(4):371-80. PubMed ID: 9054512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended tropism of an adenoviral vector does not circumvent the maturation-dependent transducibility of mouse skeletal muscle.
    van Deutekom JC; Cao B; Pruchnic R; Wickham TJ; Kovesdi I; Huard J
    J Gene Med; 1999; 1(6):393-9. PubMed ID: 10753064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene transfer establishes primacy of striated vs. smooth muscle sarcoglycan complex in limb-girdle muscular dystrophy.
    Durbeej M; Sawatzki SM; Barresi R; Schmainda KM; Allamand V; Michele DE; Campbell KP
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8910-5. PubMed ID: 12851463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice.
    Qiao C; Li J; Jiang J; Zhu X; Wang B; Li J; Xiao X
    Hum Gene Ther; 2008 Mar; 19(3):241-54. PubMed ID: 18288893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroviral-mediated gene transfer into murine and human skeletal muscle for the correction of dystrophin deficiency.
    Fassati A; Serpente P; Wells DJ; Walsh FS; Dickson G
    Biochem Soc Trans; 1996 May; 24(2):275S. PubMed ID: 8736933
    [No Abstract]   [Full Text] [Related]  

  • 11. Implications of maturation for viral gene delivery to skeletal muscle.
    van Deutekom JC; Floyd SS; Booth DK; Oligino T; Krisky D; Marconi P; Glorioso JC; Huard J
    Neuromuscul Disord; 1998 May; 8(3-4):135-48. PubMed ID: 9631393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substantial immune suppression required in gene therapy for muscular dystrophy?
    Herzog RW; Arruda VR
    Neuromuscul Disord; 2008 Jan; 18(1):83-4. PubMed ID: 18365340
    [No Abstract]   [Full Text] [Related]  

  • 13. Viral and non-viral methods for gene transfer into skeletal muscle.
    Wells DJ
    Curr Opin Drug Discov Devel; 2006 Mar; 9(2):163-8. PubMed ID: 16566286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The IVth workshop on Duchenne muscular dystrophy gene therapy.
    Schwartz K; Leterrier F
    J Gene Med; 1999; 1(6):444-8. PubMed ID: 10753071
    [No Abstract]   [Full Text] [Related]  

  • 15. rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice.
    Gregorevic P; Allen JM; Minami E; Blankinship MJ; Haraguchi M; Meuse L; Finn E; Adams ME; Froehner SC; Murry CE; Chamberlain JS
    Nat Med; 2006 Jul; 12(7):787-9. PubMed ID: 16819550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting functional subtypes of spinal motoneurons and skeletal muscle fibers in vivo by intramuscular injection of adenoviral and adeno-associated viral vectors.
    Martinov VN; Sefland I; Walaas SI; Lømo T; Njå A; Hoover F
    Anat Embryol (Berl); 2002 Jun; 205(3):215-21. PubMed ID: 12107491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus vector-mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle.
    Akkaraju GR; Huard J; Hoffman EP; Goins WF; Pruchnic R; Watkins SC; Cohen JB; Glorioso JC
    J Gene Med; 1999; 1(4):280-9. PubMed ID: 10738561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved adenoviral vectors for gene therapy of Duchenne muscular dystrophy.
    Hauser MA; Amalfitano A; Kumar-Singh R; Hauschka SD; Chamberlain JS
    Neuromuscul Disord; 1997 Jul; 7(5):277-83. PubMed ID: 9267841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus vectors based on human adenovirus type 19a have high potential for human muscle-directed gene therapy.
    Thirion C; Lochmüller H; Ruzsics Z; Boelhauve M; König C; Thedieck C; Kutik S; Geiger C; Kochanek S; Volpers C; Burgert HG
    Hum Gene Ther; 2006 Feb; 17(2):193-205. PubMed ID: 16454653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells.
    Kumar-Singh R; Chamberlain JS
    Hum Mol Genet; 1996 Jul; 5(7):913-21. PubMed ID: 8817325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.